Atom Investors LP Bristol Myers Squibb CO Transaction History
Atom Investors LP
- $782 Million
- Q1 2024
A detailed history of Atom Investors LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atom Investors LP holds 5,551 shares of BMY stock, worth $230,533. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,551
Previous 23,921
76.79%
Holding current value
$230,533
Previous $1.23 Million
75.47%
% of portfolio
0.04%
Previous 0.22%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,554Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.73 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.75 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.8 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.69 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.92 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $88.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...